Cargando…

Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China

BACKGROUND: Hypertension is a highly prevalent disorder. A nomogram to estimate the risk of hypertension in Chinese individuals is not available. METHODS: 6201 subjects were enrolled in the study and randomly divided into training set and validation set at a ratio of 2:1. The LASSO regression techni...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xinna, Hou, Huiqing, Wang, Xiaoxi, Li, Qingxia, Li, Xiuyuan, Yang, Zhaohua, Wu, Haijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163499/
https://www.ncbi.nlm.nih.gov/pubmed/34047697
http://dx.doi.org/10.7554/eLife.66419
_version_ 1783700920881643520
author Deng, Xinna
Hou, Huiqing
Wang, Xiaoxi
Li, Qingxia
Li, Xiuyuan
Yang, Zhaohua
Wu, Haijiang
author_facet Deng, Xinna
Hou, Huiqing
Wang, Xiaoxi
Li, Qingxia
Li, Xiuyuan
Yang, Zhaohua
Wu, Haijiang
author_sort Deng, Xinna
collection PubMed
description BACKGROUND: Hypertension is a highly prevalent disorder. A nomogram to estimate the risk of hypertension in Chinese individuals is not available. METHODS: 6201 subjects were enrolled in the study and randomly divided into training set and validation set at a ratio of 2:1. The LASSO regression technique was used to select the optimal predictive features, and multivariate logistic regression to construct the nomograms. The performance of the nomograms was assessed and validated by AUC, C-index, calibration curves, DCA, clinical impact curves, NRI, and IDI. RESULTS: The nomogram(140/90) was developed with the parameters of family history of hypertension, age, SBP, DBP, BMI, MCHC, MPV, TBIL, and TG. AUCs of nomogram(140/90) were 0.750 in the training set and 0.772 in the validation set. C-index of nomogram(140/90) were 0.750 in the training set and 0.772 in the validation set. The nomogram(130/80) was developed with the parameters of family history of hypertension, age, SBP, DBP, RDWSD, and TBIL. AUCs of nomogram(130/80) were 0.705 in the training set and 0.697 in the validation set. C-index of nomogram(130/80) were 0.705 in the training set and 0.697 in the validation set. Both nomograms demonstrated favorable clinical consistency. NRI and IDI showed that the nomogram(140/90) exhibited superior performance than the nomogram(130/80). Therefore, the web-based calculator of nomogram(140/90) was built online. CONCLUSIONS: We have constructed a nomogram that can be effectively used in the preliminary and in-depth risk prediction of hypertension in a Chinese population based on a 10-year retrospective cohort study. FUNDING: This study was supported by the Hebei Science and Technology Department Program (no. H2018206110).
format Online
Article
Text
id pubmed-8163499
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-81634992021-06-02 Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China Deng, Xinna Hou, Huiqing Wang, Xiaoxi Li, Qingxia Li, Xiuyuan Yang, Zhaohua Wu, Haijiang eLife Medicine BACKGROUND: Hypertension is a highly prevalent disorder. A nomogram to estimate the risk of hypertension in Chinese individuals is not available. METHODS: 6201 subjects were enrolled in the study and randomly divided into training set and validation set at a ratio of 2:1. The LASSO regression technique was used to select the optimal predictive features, and multivariate logistic regression to construct the nomograms. The performance of the nomograms was assessed and validated by AUC, C-index, calibration curves, DCA, clinical impact curves, NRI, and IDI. RESULTS: The nomogram(140/90) was developed with the parameters of family history of hypertension, age, SBP, DBP, BMI, MCHC, MPV, TBIL, and TG. AUCs of nomogram(140/90) were 0.750 in the training set and 0.772 in the validation set. C-index of nomogram(140/90) were 0.750 in the training set and 0.772 in the validation set. The nomogram(130/80) was developed with the parameters of family history of hypertension, age, SBP, DBP, RDWSD, and TBIL. AUCs of nomogram(130/80) were 0.705 in the training set and 0.697 in the validation set. C-index of nomogram(130/80) were 0.705 in the training set and 0.697 in the validation set. Both nomograms demonstrated favorable clinical consistency. NRI and IDI showed that the nomogram(140/90) exhibited superior performance than the nomogram(130/80). Therefore, the web-based calculator of nomogram(140/90) was built online. CONCLUSIONS: We have constructed a nomogram that can be effectively used in the preliminary and in-depth risk prediction of hypertension in a Chinese population based on a 10-year retrospective cohort study. FUNDING: This study was supported by the Hebei Science and Technology Department Program (no. H2018206110). eLife Sciences Publications, Ltd 2021-05-28 /pmc/articles/PMC8163499/ /pubmed/34047697 http://dx.doi.org/10.7554/eLife.66419 Text en © 2021, Deng et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Medicine
Deng, Xinna
Hou, Huiqing
Wang, Xiaoxi
Li, Qingxia
Li, Xiuyuan
Yang, Zhaohua
Wu, Haijiang
Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China
title Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China
title_full Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China
title_fullStr Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China
title_full_unstemmed Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China
title_short Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China
title_sort development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in china
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163499/
https://www.ncbi.nlm.nih.gov/pubmed/34047697
http://dx.doi.org/10.7554/eLife.66419
work_keys_str_mv AT dengxinna developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina
AT houhuiqing developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina
AT wangxiaoxi developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina
AT liqingxia developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina
AT lixiuyuan developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina
AT yangzhaohua developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina
AT wuhaijiang developmentandvalidationofanomogramtobetterpredicthypertensionbasedona10yearretrospectivecohortstudyinchina